These genes exhibited consistent differential expression patterns across multiple independent datasets and patient-derived clinical specimens, with FCER1A markedly downregulated and RGS1 significantly upregulated in individuals with SLE. This evidence concerns the gene FCER1A and systemic lupus erythematosus.